Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy

Introduction: The levels of calprotectin in the stools are proportional to neutrophil activity in the enteric lumen, so fecal calprotectin is a useful intestinal inflammatory biomarker. It is an extended tool as predictor of colonic pathology but there is scare evidence about its utility in the smal...

Full description

Bibliographic Details
Main Authors: Juan Egea-Valenzuela, Fernando Alberca-de-las-Parras, Fernando Carballo-Álvarez
Format: Article
Language:English
Published: Aran Ediciones 2015-04-01
Series:Revista Espanola de Enfermedades Digestivas
Subjects:
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082015000400004&lng=en&tlng=en
id doaj-40acb17e5993476b9221681ba0974a3a
record_format Article
spelling doaj-40acb17e5993476b9221681ba0974a3a2020-11-24T22:50:12ZengAran EdicionesRevista Espanola de Enfermedades Digestivas1130-01082015-04-011074211215S1130-01082015000400004Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopyJuan Egea-Valenzuela0Fernando Alberca-de-las-Parras1Fernando Carballo-Álvarez2Hospital Clínico Universitario Virgen de la ArrixacaHospital Clínico Universitario Virgen de la ArrixacaHospital Clínico Universitario Virgen de la ArrixacaIntroduction: The levels of calprotectin in the stools are proportional to neutrophil activity in the enteric lumen, so fecal calprotectin is a useful intestinal inflammatory biomarker. It is an extended tool as predictor of colonic pathology but there is scare evidence about its utility in the small bowel. Objective: To test the yield of fecal calprotectin to detect lesions in the small bowel. Material and methods: We have retrospectively included 71 patients sent for small bowel capsule endoscopy in study for suspected inflammatory bowel disease. All of them had a determination of fecal calprotectin and had been sent to colonoscopy with no findings. Patients have been divided in groups: A, fecal calprotectin < 50 µg/g; B, fecal calprotectin: 50-100 µg/g; C, fecal calprotectin > 100 µg/g, and we have analyzed which of them presented inflammatory lesions in capsule endoscopy studies. Results: The rate of patients with signi ficative lesions was 1 out of 10 (10%) in group A, 6 out of 24 (25%) in group B, and 21 out of 34 (62%) in group C. If we consider levels over 50 µg/g pathologic, fecal calprotectin presents sensitivity: 96%, specificity: 23%, NPV: 90% and PPV: 56%. If we consider levels over 100 µg/g pathologic these values are sensitivity: 75%, specificity: 67%, NPV: 79% and PPV: 62%. Conclusions: Fecal calprotectin has high sensitivity but not so good specificity for predicting small bowel lesions after a normal colonoscopy. In daily practice it will be more useful to establish in 100 µg/g the limit to indicate capsule endoscopy studies.http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082015000400004&lng=en&tlng=enEnfermedad de CrohnCápsula endoscópicaCalprotectina
collection DOAJ
language English
format Article
sources DOAJ
author Juan Egea-Valenzuela
Fernando Alberca-de-las-Parras
Fernando Carballo-Álvarez
spellingShingle Juan Egea-Valenzuela
Fernando Alberca-de-las-Parras
Fernando Carballo-Álvarez
Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy
Revista Espanola de Enfermedades Digestivas
Enfermedad de Crohn
Cápsula endoscópica
Calprotectina
author_facet Juan Egea-Valenzuela
Fernando Alberca-de-las-Parras
Fernando Carballo-Álvarez
author_sort Juan Egea-Valenzuela
title Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy
title_short Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy
title_full Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy
title_fullStr Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy
title_full_unstemmed Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy
title_sort fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy
publisher Aran Ediciones
series Revista Espanola de Enfermedades Digestivas
issn 1130-0108
publishDate 2015-04-01
description Introduction: The levels of calprotectin in the stools are proportional to neutrophil activity in the enteric lumen, so fecal calprotectin is a useful intestinal inflammatory biomarker. It is an extended tool as predictor of colonic pathology but there is scare evidence about its utility in the small bowel. Objective: To test the yield of fecal calprotectin to detect lesions in the small bowel. Material and methods: We have retrospectively included 71 patients sent for small bowel capsule endoscopy in study for suspected inflammatory bowel disease. All of them had a determination of fecal calprotectin and had been sent to colonoscopy with no findings. Patients have been divided in groups: A, fecal calprotectin < 50 µg/g; B, fecal calprotectin: 50-100 µg/g; C, fecal calprotectin > 100 µg/g, and we have analyzed which of them presented inflammatory lesions in capsule endoscopy studies. Results: The rate of patients with signi ficative lesions was 1 out of 10 (10%) in group A, 6 out of 24 (25%) in group B, and 21 out of 34 (62%) in group C. If we consider levels over 50 µg/g pathologic, fecal calprotectin presents sensitivity: 96%, specificity: 23%, NPV: 90% and PPV: 56%. If we consider levels over 100 µg/g pathologic these values are sensitivity: 75%, specificity: 67%, NPV: 79% and PPV: 62%. Conclusions: Fecal calprotectin has high sensitivity but not so good specificity for predicting small bowel lesions after a normal colonoscopy. In daily practice it will be more useful to establish in 100 µg/g the limit to indicate capsule endoscopy studies.
topic Enfermedad de Crohn
Cápsula endoscópica
Calprotectina
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082015000400004&lng=en&tlng=en
work_keys_str_mv AT juanegeavalenzuela fecalcalprotectinasabiomarkerofinflammatorylesionsofthesmallbowelseenbyvideocapsuleendoscopy
AT fernandoalbercadelasparras fecalcalprotectinasabiomarkerofinflammatorylesionsofthesmallbowelseenbyvideocapsuleendoscopy
AT fernandocarballoalvarez fecalcalprotectinasabiomarkerofinflammatorylesionsofthesmallbowelseenbyvideocapsuleendoscopy
_version_ 1725673469954228224